Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Volitionrx Ltd as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −4 vs. Q2 2024
- Shares held
- 17.5M
- +10.1M (+134.4%) vs. Q2 2024
- Total value
- $10.5M
- +$6.01M (+132.9%) vs. Q2 2024
- New holders
- 4
- 7 more added
- Sold out
- 8
- 4 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 8,998,727 | $5.41M | 0.14% | +8,998,727 | New |
| Lagoda Investment Management, L.P. | 6,095,000 | $3.66M | 2.10% | +657,000+12.1% | Added |
| Geode Capital Management, LLC | 730,448 | $439.1K | 0.00% | +95,900+15.1% | Added |
| Vanguard Group Inc | 636,667 | $382.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 445,187 | $267.6K | 0.00% | +445,187 | New |
| Silverberg Bernstein Capital Management LLC | 142,618 | $85.7K | 0.08% | −2,000−1.4% | Reduced |
| State Street Corp | 123,923 | $74.5K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 115,794 | $69.6K | 0.00% | +48,862+73.0% | Added |
| Northern Trust Corp | 89,296 | $53.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 56,616 | $34.0K | 0.00% | +56,616 | New |
| Ground Swell Capital, LLC | 45,959 | $27.6K | 0.04% | +20,249+78.8% | Added |
| Bridgeway Capital Management, LLC | 24,180 | $14.5K | 0.00% | −150,000−86.1% | Reduced |
| Tower Research Capital LLC (TRC) | 6,745 | $4.05K | 0.00% | −7,756−53.5% | Reduced |
| Hartford Financial Management Inc. | 5,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,400 | $2.64K | 0.00% | +3,500+388.9% | Added |
| Morgan Stanley | 2,900 | $1.74K | 0.00% | −86,325−96.7% | Reduced |
| Founders Capital Management | 2,000 | $1.20K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 588 | $353 | 0.00% | +62+11.8% | Added |
| BNP Paribas Arbitrage, SA | 265 | $159 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 200 | $121 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 200 | $120 | 0.00% | +200 | New |
| Simplex Trading, LLC | 355 | $0 | 0.00% | +30+9.2% | Added |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −15,484−100.0% | Sold out |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −7,117−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −6,244−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |